Search Menu

Articles 2019

Grau-Vorster M, Laitinen A, Nystedt J, Vives J. HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study. Stem Cell Research & Therapy 2019 Jun 13;10(1):164. PMID: 31196185

Holopainen M, Colas RA, Valkonen S, Tigistu-Sahle F, Hyvärinen K, Mazzacuva F, Lehenkari P, Käkelä R, Dalli J, Kerkelä E, Laitinen S. Polyunsaturated fatty acids modify the extracellular vesicle membranes and increase the production of proresolving lipid mediators of human mesenchymal stromal cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun 15;1864(10):1350-1362. PMID: 31207356

Jahnukainen T, Lauronen J, Raissadati A, Pihkala J, Ylinen E, Puntila J, Salminen JT, Pätilä T, Mattila IP, Jalanko H. Development of human leukocyte antigen antibodies against vascular homograft donor in pediatric heart transplant recipients. Ann Transplant. 2019 Aug 6;24:454-460. PMID: 31383839

Kivelä JM, Lempinen M, Holmberg C, Jalanko H, Pakarinen MP, Isoniemi H, Lauronen J. Renal function after combined liver-kidney transplantation: A longitudinal study of pediatric and adult patients. Pediatr Transplant. 2019 Jun;23(4):e13400. PMID: 30938071

Linjama T, Räther C, Ritari J, Peräsaari J, Eberhard HP, Korhonen M, Koskela S. Extended HLA Haplotypes and Their Impact on DPB1 Matching of Unrelated HSCT Donors. Biol Blood Marrow Transplant. 2019 Epub Jul 12. PMID: 31306777

Oja S, Kaartinen T, Ahti M, Korhonen M, Laitinen A, Nystedt J. The Utilization of Freezing Steps in Mesenchymal Stromal Cell (MSC) Manufacturing: Potential Impact on Quality and Cell Functionality Attributes. Front Immunol. 2019 Jul 16;10:1627. PMID: 31379832

Peltonen T & Ihalainen J. Evaluating Blockchain for the Governance of the Plasma Derivatives Supply Chain: How Distributed Ledger Technology Can Mitigate Plasma Supply Chain Risks. Blockchain in Healthcare Today. 2019, 2.

Raivola V, Snell K, Helén I, Partanen J. Attitudes of blood donors to their sample and data donation for biobanking. Eur J Hum Genet. 2019 Epub May 30. PMID: 31147625

Ritari J, Hyvärinen K, Koskela S, Niittyvuopio R, Nihtinen A, Salmenniemi U, Putkonen M, Volin L, Kwan T, Pastinen T, Itälä-Remes M, Partanen J. Computational analysis of HLA-presentation of non-synonymous recipient mismatches indicates effect on the risk of chronic graft-versus-host disease after allogeneic HSCT. Front Immunol. 2019 Jul 16;10:1625. PMID: 31379830

Rygård SL, Grønlykke L, Perner A, Winkel P, Lange T, Broksø Holst L, Johansson PI, Aneman A, Brodersen T, Laurén E, Ullum H, Wetterslev J. Storage time of red blood cells among ICU patients with septic shock. Acta Anaesthesiol Scand. 2019 Epub Jul 8. PMID: 31283834

Rytkönen S, Ritari J, Peräsaari J, Saarela V, Nuutinen M, Jahnukainen T. IL-10 polymorphisms +434T/C, +504G/T, and -2849C/T may predispose to tubulointersititial nephritis and uveitis in pediatric population. PLoS One. 2019 Feb 19;14(2):e0211915. PMID: 30779760

Salmenkari H, Laitinen A, Forsgård RA, Holappa M, Lindén J, Pasanen L, Korhonen M, Korpela R, Nystedt J. The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study. Cytotherapy. 2019 Feb;21(2):175-188. PMID: 30611671 

Valkonen S, Mallas B, Impola U, Valkeajärvi A, Eronen J, Javela K, Siljander P, Laitinen S. Assessment of time-dependent platelet activation using extracellular vesicles, CD62P exposure, and soluble glycoprotein V content of platelet concentrates with two different platelet additive solutions. Transfus Med Hemother. 2019 46:267–275.

Valkonen S, Holopainen M, Colas RA, Impola U, Dalli J, Käkelä R, Siljander PR, Laitinen S. Lipid mediators in platelet concentrate and extracellular vesicles: Molecular mechanisms from membrane glycerophospholipids to bioactive molecules. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Aug;1864(8):1168-1182. PMID: 30980920


Ilmakunnas M & Sainio S. Kenelle O RhD -negatiivisia punasoluja? Duodecim 2019;135(3):229-31.

Siljander P, Valkonen S, Laitinen S, Kerkelä E. Verisolujen solunulkoiset vesikkelit. Duodecim 2019;135:663–71.


Irving A, Higgins A, Ady B, Bellomo R, Cooper DJ, French C, Gantner D, Harris A, Irving DO, Murray L, Nichol A, Petrie D, McQuilten ZK; Standard Issue Transfusion versus Fresher Red-Cell Use in Intensive Care (TRANSFUSE) Investigators and Australian and New Zealand Intensive Care Society Clinical Trials Group. Fresh Red Cells for Transfusion in Critically Ill Adults: An Economic Evaluation of the Standard Issue Transfusion Versus Fresher Red-Cell Use in Intensive Care (TRANSFUSE) Clinical Trial. Crit Care Med. 2019 Jul;47(7):e572-e579. PMID: 31008734